Tvardi Therapeutics
Latest round
- Series B
Last raised
- Jun 2021
Total raised
- $112M
Investors
- 6
About Tvardi Therapeutics
Tvardi Therapeutics is focused on developing innovative oral small molecule therapies targeting STAT3 to address fibrosis-related diseases.Tvardi Therapeutics, Inc. was founded in 2017 in Houston, US. The company specializes in the development of therapies for chronic fibrosis-driven diseases such as idiopathic pulmonary fibrosis (IPF).42 mn on June 3, 2021.Tvardi Therapeutics specializes in the development of innovative, oral small molecule therapies aimed at targeting STAT3 to address fibrosis-driven diseases with significant unmet medical needs. The company’s core product offerings focus on conditions like idiopathic pulmonary fibrosis (IPF), which currently lacks effective treatments.Tvardi Therapeutics generates revenue through partnerships and collaborations with pharmaceutical companies and research institutions that aid in the development and commercialization of its therapies. Collaborative agreements allow partners to access Tvardi's proprietary products and technology, with specific pricing structures reflecting their value.42 mn to advance its product candidates through multiple clinical data readouts in mid-stage trials for cancer and fibrosis. The company is also focused on expanding into North American and European markets, enhancing its presence among healthcare providers and research institutions. These strategic initiatives aim to significantly enhance the company's portfolio and market reach by targeting regions with high unmet medical needs.
Who invested in Tvardi Therapeutics
6 investors across 2 rounds
See all investors in Tvardi Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tvardi Therapeutics
Who invested in Tvardi Therapeutics?
Tvardi Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tvardi Therapeutics raised?
Tvardi Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tvardi Therapeutics last raise money?
Tvardi Therapeutics's most recent round on record is a Series B, in Jun 2021.
What does Tvardi Therapeutics do?
Tvardi Therapeutics is focused on developing innovative oral small molecule therapies targeting STAT3 to address fibrosis-related diseases.
Where is Tvardi Therapeutics headquartered?
Tvardi Therapeutics is headquartered in Houston, US.
Which VCs invest in companies like Tvardi Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tvardi Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Tvardi Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.